At a time when global uncertainty, AI-led disruptions and rapid instittuional foreign selling have led to a broad-based drawdowns in the Indian market, Take Solutions has emerged as a rare winner. In fact, it is not only a winner anymore, it has become one of the success stories in the Indian broader market over the past 12 months, having given a whopping returns of 466% during this period.
However, it wasn't always smooth sailing for Take Solutions, which is the business of life sciences and support services. Once trading near Rs 250 in 2018, the small-cap IT and life sciences firm had collapsed under the weight of debt, forced asset sales and shrinking operations. The stock eventually sank to a lifetime low of Rs 6.5 by April 2025.
But fast forward to April 2026, the story of Take Solutions has flipped dramatically. Since November of last year, the stock has rallied relentlessly, often hitting upper circuits with unusually high volumes. With 466% returns in the past year, Take Solutions has become one of the broader market's biggest turnaround stories.
How Did Take Solutions Pull It Off?
A whole lot of reasons have played a part in helping Take Solutions pull off the successful turnaround, one of them being a a painful restructuring. Key subsidiaries such as Navitas Life Sciences and Acunova entities were divested in light of the loan defaults and enforced sales to HIG Capital affiliates.
ALSO READ: Late Siddhartha Bhaiya's Bold Strategy Of Spotting Multibaggers
Not to mention, the firm's smart pivot into AI-led capabilities in clinical research, life sciences, healthcare, consumer wellness have paid off. As a result, balance sheets improved, with the company's peak debt of Rs 2,400 crore in March 2020 going down to Rs 35 crore, as of September 2025.
Another Pivot: Anti-ageing
The company, though, is now left with Ecron Acunova as its primary remaining operational asset. Meaning the road ahead could be crucial and that is where the recent development comes into focus. Take Solutions on Friday announced a pivot into one of the buzzing themes in global healthcare: Anti-ageing and longevity.
Take Solutions is planning to develop science-backed nutraceuticals, biohacking solutions and technology-enabled preventive healthcare offerings.
This is a critical pivot, with the management is framing this as a natural extension of TAKE's long-standing experience in clinical research, life sciences, and regulatory execution.
The timing is hard to ignore either. India's preventive healthcare market is estimated at about $197 billion, while the global market is projected to grow rapidly over the next decade or so. Rising lifestyle diseases, growing health awareness and a smartphone-first population are reshaping these trends.
Take Solutions is ready to bet heavily on this shift. However, as of now, The company has merely outlined their ambition and is yet to show any execution. As per latest data available, their P&L still reads zero and it will be interesting to see if the company can follow up with partnerships, launches and operational manoeuvre in the near future.
ALSO READ: Allbirds Shares Fly 400% After Radical Pivot To AI Infra Business
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
